Literature DB >> 21515544

Normalized names for clinical drugs: RxNorm at 6 years.

Stuart J Nelson1, Kelly Zeng, John Kilbourne, Tammy Powell, Robin Moore.   

Abstract

OBJECTIVE: In the 6 years since the National Library of Medicine began monthly releases of RxNorm, RxNorm has become a central resource for communicating about clinical drugs and supporting interoperation between drug vocabularies.
MATERIALS AND METHODS: Built on the idea of a normalized name for a medication at a given level of abstraction, RxNorm provides a set of names and relationships based on 11 different external source vocabularies. The standard model enables decision support to take place for a variety of uses at the appropriate level of abstraction. With the incorporation of National Drug File Reference Terminology (NDF-RT) from the Veterans Administration, even more sophisticated decision support has become possible. DISCUSSION: While related products such as RxTerms, RxNav, MyMedicationList, and MyRxPad have been recognized as helpful for various uses, tasks such as identifying exactly what is and is not on the market remain a challenge.

Mesh:

Substances:

Year:  2011        PMID: 21515544      PMCID: PMC3128404          DOI: 10.1136/amiajnl-2011-000116

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  20 in total

1.  Evaluation of a proposed method for representing drug terminology.

Authors:  J J Cimino; T J McNamara; T Meredith; C A Broverman; K C Eckert; M Moore; D J Tyree
Journal:  Proc AMIA Symp       Date:  1999

2.  A semantic normal form for clinical drugs in the UMLS: early experiences with the VANDF.

Authors:  Stuart J Nelson; Steven H Brown; Mark S Erlbaum; Nels Olson; Tammy Powell; Brian Carlsen; John Carter; Mark S Tuttle; William T Hole
Journal:  Proc AMIA Symp       Date:  2002

3.  Analysis of identifier performance using a deterministic linkage algorithm.

Authors:  Shaun J Grannis; J Marc Overhage; Clement J McDonald
Journal:  Proc AMIA Symp       Date:  2002

4.  Health information technology: initial set of standards, implementation specifications, and certification criteria for electronic health record technology. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2010-07-28

5.  The "meaningful use" regulation for electronic health records.

Authors:  David Blumenthal; Marilyn Tavenner
Journal:  N Engl J Med       Date:  2010-07-13       Impact factor: 91.245

6.  RxNav: a web service for standard drug information.

Authors:  Kelly Zeng; Olivier Bodenreider; John Kilbourne; Stuart Nelson
Journal:  AMIA Annu Symp Proc       Date:  2006

7.  Design and implementation of a personal medication record-MyMedicationList.

Authors:  Kelly Zeng; Olivier Bodenreider; Stuart J Nelson
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06

8.  RxTerms - a drug interface terminology derived from RxNorm.

Authors:  Kin Wah Fung; Clement McDonald; Bruce E Bray
Journal:  AMIA Annu Symp Proc       Date:  2008-11-06

Review 9.  Medication-related clinical decision support in computerized provider order entry systems: a review.

Authors:  Gilad J Kuperman; Anne Bobb; Thomas H Payne; Anthony J Avery; Tejal K Gandhi; Gerard Burns; David C Classen; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2006-10-26       Impact factor: 4.497

10.  Building a standards-based and collaborative e-prescribing tool: MyRxPad.

Authors:  Stuart J Nelson; Kelly Zeng; John Kilbourne
Journal:  Int J Data Min Bioinform       Date:  2011       Impact factor: 0.667

View more
  138 in total

1.  Using Electronic Health Records To Generate Phenotypes For Research.

Authors:  Sarah A Pendergrass; Dana C Crawford
Journal:  Curr Protoc Hum Genet       Date:  2018-12-05

2.  A method for systematic discovery of adverse drug events from clinical notes.

Authors:  Guan Wang; Kenneth Jung; Rainer Winnenburg; Nigam H Shah
Journal:  J Am Med Inform Assoc       Date:  2015-07-31       Impact factor: 4.497

Review 3.  Medication-indication knowledge bases: a systematic review and critical appraisal.

Authors:  Hojjat Salmasian; Tran H Tran; Herbert S Chase; Carol Friedman
Journal:  J Am Med Inform Assoc       Date:  2015-09-02       Impact factor: 4.497

4.  Evaluating the implementation of RxNorm in ambulatory electronic prescriptions.

Authors:  Ajit A Dhavle; Stacy Ward-Charlerie; Michael T Rupp; John Kilbourne; Vishal P Amin; Joshua Ruiz
Journal:  J Am Med Inform Assoc       Date:  2015-10-28       Impact factor: 4.497

Review 5.  Unravelling the human genome-phenome relationship using phenome-wide association studies.

Authors:  William S Bush; Matthew T Oetjens; Dana C Crawford
Journal:  Nat Rev Genet       Date:  2016-02-15       Impact factor: 53.242

6.  Characterizing the sublanguage of online breast cancer forums for medications, symptoms, and emotions.

Authors:  Noémie Elhadad; Shaodian Zhang; Patricia Driscoll; Samuel Brody
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

7.  Using aggregated, de-identified electronic health record data for multivariate pharmacosurveillance: a case study of azathioprine.

Authors:  Vishal N Patel; David C Kaelber
Journal:  J Biomed Inform       Date:  2013-10-28       Impact factor: 6.317

8.  Chronology of your health events: approaches to extracting temporal relations from medical narratives.

Authors:  Özlem Uzuner; Amber Stubbs; Weiyi Sun
Journal:  J Biomed Inform       Date:  2013-12       Impact factor: 6.317

9.  Causal inference on electronic health records to assess blood pressure treatment targets: an application of the parametric g formula.

Authors:  Kipp W Johnson; Benjamin S Glicksberg; Rachel A Hodos; Khader Shameer; Joel T Dudley
Journal:  Pac Symp Biocomput       Date:  2018

10.  Heart beats in the cloud: distributed analysis of electrophysiological 'Big Data' using cloud computing for epilepsy clinical research.

Authors:  Satya S Sahoo; Catherine Jayapandian; Gaurav Garg; Farhad Kaffashi; Stephanie Chung; Alireza Bozorgi; Chien-Hun Chen; Kenneth Loparo; Samden D Lhatoo; Guo-Qiang Zhang
Journal:  J Am Med Inform Assoc       Date:  2013-12-10       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.